|
gptkbp:instanceOf
|
gptkb:scientist
chemist
|
|
gptkbp:almaMater
|
gptkb:University_of_Szeged
|
|
gptkbp:awardReceived
|
gptkb:Breakthrough_Prize_in_Life_Sciences
gptkb:Japan_Prize
gptkb:Nobel_Prize_in_Physics
gptkb:Princess_of_Asturias_Award_for_Technical_and_Scientific_Research
gptkb:Time_100
gptkb:Louisa_Gross_Horwitz_Prize
gptkb:Paul_Ehrlich_and_Ludwig_Darmstaedter_Prize
gptkb:Benjamin_Franklin_Medal_in_Life_Science
gptkb:Gairdner_International_Award
gptkb:Lasker-DeBakey_Clinical_Medical_Research_Award
gptkb:Tang_Prize_in_Biopharmaceutical_Science
|
|
gptkbp:birthDate
|
1955-01-17
|
|
gptkbp:birthPlace
|
gptkb:Szolnok
|
|
gptkbp:children
|
gptkb:Susan_Francia
|
|
gptkbp:citizenship
|
gptkb:Hungary
gptkb:United_States
|
|
gptkbp:collaboratedWith
|
gptkb:Drew_Weissman
|
|
gptkbp:doctoralAdvisor
|
gptkb:Jenő_Tomasz
|
|
gptkbp:employer
|
gptkb:University_of_Pennsylvania
gptkb:BioNTech
gptkb:Szeged_Biological_Research_Centre
|
|
gptkbp:field
|
biochemistry
molecular biology
|
|
gptkbp:gender
|
female
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Katalin Karikó
|
|
gptkbp:influenced
|
gptkb:COVID-19_mRNA_vaccines
|
|
gptkbp:knownFor
|
COVID-19 vaccine development
mRNA technology
|
|
gptkbp:language
|
English
Hungarian
|
|
gptkbp:memberOf
|
gptkb:Hungarian_Academy_of_Sciences
gptkb:National_Academy_of_Sciences_(USA)
gptkb:European_Molecular_Biology_Organization
|
|
gptkbp:nationality
|
Hungarian
|
|
gptkbp:notableWork
|
Development of modified mRNA for therapeutic use
Research on nucleoside-modified mRNA
|
|
gptkbp:residence
|
gptkb:Germany
gptkb:United_States
|
|
gptkbp:spouse
|
gptkb:Béla_Francia
|
|
gptkbp:thesisTitle
|
Synthesis and characterization of interferon-induced proteins
|
|
gptkbp:thesisYear
|
1982
|
|
gptkbp:website
|
https://www.katalinkariko.com/
|
|
gptkbp:bfsParent
|
gptkb:American_Association_for_the_Advancement_of_Science
gptkb:American_Philosophical_Society
gptkb:COVID-19
gptkb:John_Scott_Medal
gptkb:University_of_California
|
|
gptkbp:bfsLayer
|
4
|